RNA-Seq

How Low Can You Go? Advantages of low-input RNA-seq over single-cell RNA-seq Do you believe RNA sequencing has become an essential tool in addressing biological questions? That it is a powerful [...]

The Cofactor team can most often be found in our St. Louis laboratory, or our San Francisco offices.  But, sometimes we hit the road to share our latest work with our customers, collaborators, [...]

Cofactor’s mission is to provide the best quality data and support to our customers.  To meet this – we’re making some exciting updates! Electronic Data Delivery: Faster access to your data [...]

Cofactor is proud to announce that key members of our Executive and R&D teams will be on the ground at ASCO 2016 in Chicago: In addition to seeing the latest advances of our colleagues, we [...]

Welcome to my first blog post! In dealing with samples obtained in the clinic, as many researchers frequently do, often only a small amount of tissue is available.  RNA-Seq from low input amounts [...]

Three years ago we set out on a mission to transform Cofactor into a company that would lead our industry in pre-clinical discovery services using RNA and clinical tests that would fully leverage [...]

There is a ton of potential in circular RNA (circRNA) for both diagnostic and therapeutic applications.  While previously thought to be a spurious result of aberrant splicing, the biogenesis of [...]

Cofactor recently presented a poster at AGBT 2016, in collaboration with NuGEN, and I thought it might be interesting to share it here (in a blog format) for those of you who were not able to [...]

Two weeks back I attended AGBT and had such a great time I thought I would share some highlights from our collaborative research with Pacific Biosciences. The motivation: Cofactor has solutions [...]

Don’t Miss our Exciting Work in RNA Discovery with our Collaborators from Pacific Biosciences and Nugen   (Hint, we will be the ones wearing orange jackets) Representatives from [...]